Baxdela OverviewDelafloxacin (INN) (trade name Baxdela) is a fluoroquinolone antibiotic used to treat acute bacterial skin and skin structure infections. It was developed and marketed by Melinta Therapeutics (formerly Rib-X Pharmaceuticals), which subsequently merged with Cempra. Contents 1 Medical use 2 Adverse effects 3 Interactions 4 Pharmacology 5 Chemistry 6 History 7 References Medical use Delafloxacin is used to treat acute bacterial skin and skin structure infections caused by de...
Read more Baxdela Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Delafloxacin
Recent Baxdela Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 300mg
- Powder: 300mg/vial
- Tablet: 450mg
NDC Database Records for Baxdela: (2 results)Sorted by National Drug Code
- 70842-101 Baxdela 450 mg Oral Tablet by Melinta Therapeutics, Inc
- 70842-102 Baxdela 300 mg/10.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Melinta Therapeutics, Inc